Literature DB >> 27066931

Transitional care clinics for follow-up and primary care linkage for patients discharged from the ED.

Kailyn Elliott1, Jared W Klein2, Anirban Basu3, Amber K Sabbatini4.   

Abstract

OBJECTIVES: Transitional care clinics (TCCs) represent one strategy to facilitate follow-up and primary care linkage for patients with no regular source of care who are discharged from the emergency department (ED). We assessed factors associated with completion of TCC follow-up among these patients and characterized their subsequent ED use.
METHODS: Retrospective study of 660 randomly sampled patients with a scheduled appointment to a TCC at time of ED discharge. Patient- and visit-level characteristics were abstracted from the medical records of these patients and linked to a state visit database to characterize ED use after referral. Multiple logistic regression was used to determine factors associated with completion of follow-up and subsequent ED utilization.
RESULTS: Half (50%) of the patients completed their follow-up appointment with a mean follow-up time of 6.9days. Non-English language (odds ratio [OR], 2.21; confidence interval [CI], 1.30-3.75) was the only factor associated with improved follow-up; however, patients who were homeless (OR, 0.42; CI, 0.26-0.66) had a substance use history (OR, 0.68; CI, 0.45-1.00), and those with more baseline ED visits (OR, 0.94 per additional ED visit; CI, 0.89-0.99) were significantly less likely to complete follow-up. After adjusting for demographic, clinical, and visit-level characteristics, patients who completed their appointment had significantly fewer ED visits in the subsequent year compared to patients who did not complete their appointment (mean, 2.3 vs 3.3 visits; difference, -1.0 visits in subsequent calendar year; CI for difference, -1.2 to -0.7).
CONCLUSION: Transitional care clinics represent a promising strategy to improve the continuity of care for emergency patients and may reduce unnecessary ED use. Published by Elsevier Inc.

Entities:  

Mesh:

Year:  2016        PMID: 27066931     DOI: 10.1016/j.ajem.2016.03.029

Source DB:  PubMed          Journal:  Am J Emerg Med        ISSN: 0735-6757            Impact factor:   2.469


  7 in total

1.  Collaborative care from the emergency department for injured patients with prescription drug misuse: An open feasibility study.

Authors:  Lauren K Whiteside; Doyanne Darnell; Karlee Jackson; Jin Wang; Joan Russo; Dennis M Donovan; Douglas F Zatzick
Journal:  J Subst Abuse Treat       Date:  2017-08-24

2.  Followup Care after Emergency Department Visits for Kidney Stones: A Missed Opportunity.

Authors:  Amy N Luckenbaugh; Phyllis L Yan; Casey A Dauw; Khurshid R Ghani; Brent K Hollenbeck; John M Hollingsworth
Journal:  Urol Pract       Date:  2018-12-27

3.  Rapid Primary Care Follow-up from the ED to Reduce Avoidable Hospital Admissions.

Authors:  Amanda S Carmel; Peter Steel; Robert Tanouye; Aleksey Novikov; Sunday Clark; Sanjai Sinha; Judy Tung
Journal:  West J Emerg Med       Date:  2017-07-14

4.  Resource consumption of multi-substance users in the emergency room: A neglected patient group.

Authors:  Laurence Klenk; Christina von Rütte; Jonathan F Henssler; Thomas C Sauter; Wolf E Hautz; Aristomenis K Exadaktylos; Martin Müller
Journal:  PLoS One       Date:  2019-09-26       Impact factor: 3.240

5.  Frequent Emergency Department Visits After Spontaneous Intracerebral Hemorrhage: Who Is at Risk?

Authors:  Jerina Nogueira; Pedro Abreu; Patrícia Guilherme; Ana Catarina Félix; Fátima Ferreira; Hipólito Nzwalo; Ana Marreiros
Journal:  Neurohospitalist       Date:  2018-02-07

6.  Ophthalmic Emergency Department Visits: Factors Associated With Loss to Follow-up.

Authors:  Evan M Chen; Aneesha Ahluwalia; Ravi Parikh; Kristen Nwanyanwu
Journal:  Am J Ophthalmol       Date:  2020-09-01       Impact factor: 5.258

Review 7.  Patient navigators facilitating access to primary care: a scoping review.

Authors:  Annette Peart; Virginia Lewis; Ted Brown; Grant Russell
Journal:  BMJ Open       Date:  2018-03-17       Impact factor: 2.692

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.